<?xml-stylesheet type="text/xsl" href="https://dochub.sk.ru/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Russia Accepts BN006 as a Skolkovo Innovation Priority</title><link>/foundation/biomed/b/weblog3/archive/2013/07/17/russia-accepts-bn006-as-a-skolkovo-innovation-priority.aspx</link><description>Bone Medical is pleased to announce that its BN006 programme for rheumatoid arthritis (RA) has been accepted as an innovation priority by The Skolkovo Foundation, the Russian government backed non-profit organization formed to stimulate the development</description><dc:language /><generator>7.x Production</generator></channel></rss>